# Comparative Efficacy of hUCMSC-Secretome Delivered Via Microneedling and Intradermal Microinjection as Adjuvant Therapy to NB-UVB in Nonsegmental Vitiligo: A Quasi-Experimental Study

> **NCT07509242** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Yohanes Firmansyah, dr, MH, MM** · enrollment: 150 (estimated)

## Conditions studied

- Vitiligo

## Interventions

- **OTHER:** NB-UVB combined with microneedling and topical 10% secretome
- **OTHER:** receives NB-UVB combined with intradermal secretome injection
- **DRUG:** NB-UVB alone

## Key facts

- **NCT ID:** NCT07509242
- **Lead sponsor:** Yohanes Firmansyah, dr, MH, MM
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-18
- **Primary completion:** 2027-01-18
- **Final completion:** 2028-01-18
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07509242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07509242, "Comparative Efficacy of hUCMSC-Secretome Delivered Via Microneedling and Intradermal Microinjection as Adjuvant Therapy to NB-UVB in Nonsegmental Vitiligo: A Quasi-Experimental Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07509242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*